Nearly 20 years ago, scientists stunned the world when they announced they had decoded the genes that make up a human being. As we first reported last March, they hoped to use that genetic blueprint ...

Johnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA), seeking approval of IMAAVY® ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal ...

Vonjo (pacritinib) improves hemoglobin levels in myelofibrosis patients with anemia, aligning with clinical guidelines for anemia management. The study showed 44% of patients achieved a hemoglobin ...

Treating anemia in patients with CKD earlier, before hemoglobin levels fall below 9.0 g/dL, may reduce risks for cardiovascular events. Delaying renal anemia treatment with long-acting ...

Please provide your email address to receive an email when new articles are posted on . Men with anemia were more likely to have correction of their condition with testosterone therapy vs. placebo.

Investigators said several new anemia therapies are in development, and many of them may help wide swaths of patients. A wave of new therapies is starting to reshape the treatment landscape for people ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

Anemia is a common complication of HIV. There are numerous possible causes, including HIV itself, related infections, and some HIV medications. Taking certain medications and adjusting nutrition may ...

Akebia Therapeutics will not start a proposed trial for its anemia treatment after meeting with the Food and Drug Administration. The biopharmaceutical company said Tuesday it believes regulatory ...